Clinical outcomes of hyperprogression based on volumetry in non-small cell lung cancer after immune checkpoint inhibitor treatment.
Kim J, Kim T, Jang TW, Kang H, Kim MH, Yoon SH, Son CH, Lee HK, Kim HK, Lee SY, Shin KC, Han JY, Kang EJ.
Kim J, et al. Among authors: kim hk, kim t, kim mh.
Thorac Cancer. 2022 Aug;13(15):2170-2179. doi: 10.1111/1759-7714.14539. Epub 2022 Jul 3.
Thorac Cancer. 2022.
PMID: 35785522
Free PMC article.